Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Bussini

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Journal of Fungi (Basel, Switzerland)|April 21, 2022
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and ConclusionsMatthias Egger, Linda Bussini, Martin Hoenigl, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 31, 2024
Dialysis-associated infection prevention and surveillance trial: an easy, feasible and effective bundle for infection preventionMichele Bartoletti, Linda Bussini, Davide Fiore Bavaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 13, 2026
'Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia' - Author's replyBenedetta Varisco, Linda Bussini, Davide Fiore Bavaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2023
What do clinicians mean by epidemics' preparednessMichele Bartoletti, Linda Bussini, Davide Fiore Bavaro, et al.
Expert Review of Molecular Diagnostics|December 13, 2021
Rapid diagnostic tests in the management of pneumoniaEleonora Riccobono, Linda Bussini, Maddalena Giannella, et al.
Microorganisms|April 23, 2022
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological PatientPaolo Gaibani, Linda Bussini, Stefano Amadesi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 30, 2023
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patientsPaolo Gaibani, Federica Bovo, Linda Bussini, et al.
The Journal of Antimicrobial Chemotherapy|April 4, 2022
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatmentsPaolo Gaibani, Federica Bovo, Linda Bussini, et al.
Infectious Diseases (London, England)|July 8, 2017
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study)Leonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli, et al.
HIV Clinical Trials|April 20, 2017
Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatmentLeonardo Calza, Vincenzo Colangeli, Eleonora Magistrelli, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Journal of Fungi (Basel, Switzerland)|April 21, 2022
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and ConclusionsMatthias Egger, Linda Bussini, Martin Hoenigl, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 31, 2024
Dialysis-associated infection prevention and surveillance trial: an easy, feasible and effective bundle for infection preventionMichele Bartoletti, Linda Bussini, Davide Fiore Bavaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 13, 2026
'Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia' - Author's replyBenedetta Varisco, Linda Bussini, Davide Fiore Bavaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2023
What do clinicians mean by epidemics' preparednessMichele Bartoletti, Linda Bussini, Davide Fiore Bavaro, et al.
Expert Review of Molecular Diagnostics|December 13, 2021
Rapid diagnostic tests in the management of pneumoniaEleonora Riccobono, Linda Bussini, Maddalena Giannella, et al.
Microorganisms|April 23, 2022
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological PatientPaolo Gaibani, Linda Bussini, Stefano Amadesi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 30, 2023
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patientsPaolo Gaibani, Federica Bovo, Linda Bussini, et al.
The Journal of Antimicrobial Chemotherapy|April 4, 2022
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatmentsPaolo Gaibani, Federica Bovo, Linda Bussini, et al.
Infectious Diseases (London, England)|July 8, 2017
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study)Leonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli, et al.
HIV Clinical Trials|April 20, 2017
Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatmentLeonardo Calza, Vincenzo Colangeli, Eleonora Magistrelli, et al.
Pageof 6